tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
RPRX
Royalty Pharma
RESEARCH TOOLSreports
Want to see RPRX full AI Analyst Report?

Royalty Pharma (RPRX) Income Statement

1,303 Followers

Royalty Pharma Income Statement

Last quarter (Q4 2025), Royalty Pharma's total revenue was $621.99M, an increase of 4.78% from the same quarter last year. In Q4, Royalty Pharma's net income was $214.21M. See Royalty Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.38B$ 2.26B$ 2.35B$ 2.24B$ 2.29B
Gross Profit
$ 2.38B$ 2.26B$ 2.35B$ 2.24B$ 2.29B
Operating Expenses
$ 818.67M$ 971.13M$ 862.40M$ 1.93B$ 858.75M
Depreciation and Amortization
$ 3.85M$ 0.00$ 0.00$ 5.67M$ 23.00M
EBITDA
$ 1.64B$ 1.56B$ 1.89B$ 423.69M$ 1.43B
Operating Income
$ 1.56B$ 1.29B$ 1.49B$ 307.06M$ 1.43B
Other Income/Expenses
$ -235.33M$ 38.37M$ 207.94M$ -77.00M$ -189.51M
Pretax Income
$ 1.32B$ 1.33B$ 1.70B$ 230.06M$ 1.24B
Net Income
$ 770.95M$ 858.98M$ 1.13B$ 42.83M$ 619.73M
Per Share Metrics
Basic EPS
$ 2.33$ 1.92$ 3.41$ 0.10$ 1.49
Diluted EPS
$ 1.80$ 1.91$ 2.53$ 0.10$ 1.49
Weighted Average Shares Outstanding
 431.89M 445.99M 447.60M 437.96M 414.79M
Weighted Average Shares Outstanding (Diluted)
 559.61M 594.00M 602.90M 437.97M 414.80M
Currency in USD

Royalty Pharma Earnings and Revenue History